What is Gout?
Gout is a form of inflammatory arthritis with distinct characteristics. It manifests through acute attacks featuring intense pain, redness, swelling, and heat in the affected joint. These symptoms typically emerge during the night, reaching their peak within 12-24 hours. The pain is excruciating, prompting many individuals to seek emergency care, contributing to gout surpassing Rheumatoid Arthritis in annual hospital admissions for rheumatological conditions.
The underlying mechanism involves the crystallisation of urate, a byproduct of urea metabolism, within the joint. Either an excess of urea in the body (constituting 90% of cases) or a diminished ability to produce urate triggers the formation of these crystals, sparking synovitis and the associated symptoms. When the joint is aspirated, the presence of urate crystals becomes evident, confirming the diagnosis.
Who Gets Gout?
Gout, impacts approximately 2.5% of the population, exhibits geographical variations, with higher prevalence noted in the North West of England and Wales. The gender distribution reveals that 1 in 14 men and 1 in 35 women are affected, emphasising a higher incidence in males. Notably, onset before puberty in men and before menopause in women is uncommon.
The 1st metatarsophalangeal joint (1st MTPJ), stands out as the primary target for gout, constituting 75% of cases at initial onset. The joints affected then move proximally with the midfoot and ankle next highest affected, followed by any other peripheral synovial joint. The more attacks that occur, the more likely that other joints and/or multiple joints become affected.
Beyond demographics, gout is intricately linked to various co-morbidities. Conditions such as diabetes, cardiovascular disease, stroke, obesity, and impaired kidney function are associated with an increased likelihood of developing gout. Dietary habits also play a crucial role, with high alcohol and red meat intake emerging as significant risk factors. The correlation between lifestyle choices and gout highlights the multifaceted nature of this condition, encouraging a comprehensive approach to its prevention and management. Understanding the demographic and lifestyle factors contributing to gout not only aids in early detection but also guides targeted interventions and lifestyle modifications to mitigate its impact on individuals' health.
What Do We Do?
In addressing gout, a structured approach is crucial, particularly in managing the first attack and addressing ongoing treatment. For individuals experiencing their initial gout episode, prompt consultation with a General Practitioner (GP) is advised. The immediate management involves Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Colchicine to alleviate the acute flare, followed by a gradual titration of Allopurinol to regulate uric acid levels. While physiotherapy yields limited benefits in the early stages, educating patients about the condition, coupled with providing symptomatic relief through measures like ice application and NSAIDs, contributes to a more comprehensive approach.
It is worth noting that there is currently an ongoing discussion about NSAIDs compared to Colchicine to manage acute flares. Cochicine may be associated with more adverse outcomes.
For those already on medication, a careful discussion of the ongoing treatment plan is essential. It's common for a gout flare to be triggered by the initiation of Allopurinol, underscoring the need for a thoughtful and patient-centered approach. Titration of the Allopurinol dose is necessary until effective control is achieved, requiring close monitoring. Although primary care plays a pivotal role in most cases, collaboration with Rheumatology specialists is recommended, especially in the early stages of the disease and when faced with refractory cases. This collaborative effort ensures a holistic management strategy, combining both immediate relief and long-term control, to optimize outcomes and enhance the patient's quality of life.
Audio and Video Versions